Shenzhen Hepalink Pharmaceutical Group. (9989.HK) Q3 2025 Earnings

29AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
0.02
0.14
0.26
0.38

Details

Expected EPS
0.02175255162
Actual EPS
0.19577296458
Surprise EPS
0.17
Surprise Percent
+800%

Description

Shenzhen Hepalink Pharmaceutical Group. (9989.HK) has reported earnings of 0.19577296458 per share for Q3 2025.

0 Comments

Share your thoughts